Sarclisa (isatuximab-irfc) for the Treatment of Multiple Myeloma

Sarclisa was approved by the US Food and Drug Administration (FDA) in March 2020. Credit: Sanofi-Aventis.



  • Sarclisa
  • Sarclisa
  • Sarclisa
  • Sarclisa